The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Someone knows something?
Still shifting
well it looks like there may be a bit of momentum trading. Be interesting to see where it rests after the trading is done
Today. Let’s see what happens this week
Lol! Fingers crossed
maybe this time.......
All red and down we go.
So disappointing
Just need Clive to confirm the molecules are ready and partnered!
Only a small ask after more than a year of no discernible news other than shareholder dilution and promises of good times to come...
Let’s hope it’s delivery time now
As she goes, then some explosive news !!!!, thats what we want. Gla
I think there’s a few buyers. Rising
triggered a little bit of buying. Probably one person accumulating a few.
@18p
News afoot?
terms seem similar to that of C4XD's with Indivior. Already added £60M to MCAP in early trading
(I know AZ is a different beast but food for thought)
Trust me, this will be 50p within a month from now. Indivior payment to be announced in august, but the suprise coming is a new deal for license NRTF2.
Its a big one,
milestone payment in August?
INDV-1000 (Selective Orexin 1 [OX1] receptor antagonist):
- On September 26, 2019 the National Institutes of Health (NIH) granted Indivior’s application
entitled “Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for
the Treatment of Opioid Use Disorder” pursuant to Funding Opportunity Announcement RFA-DA-19-002
dedicated to the development of medications to prevent and treat opioid use disorder and overdose.
Page | 2
- Our development plans were presented at the first HEAL Investigator Meeting in Bethesda on January 16-
17, 2020 (see publication list).
- The Single Ascending Dose (SAD) study was planned to start in April 2020 but was delayed by
approximately 3 months due to the COVID-19 pandemic. The first dosing in Man is currently scheduled for
August 2020.
- Nonclinical pivotal toxicokinetics and embryofetal studies have been completed.
Would be nice.
An update from the Company would be even nicer!
WHat is the point of incentivised options if they can change the goalposts, they can’t lose. Still think this will work out in the long term.
Yes, the buck stops with the CEO, LTHs just have to suck it up and wait and hope it returns to the levels they bought they don’t get the chance to change the price they bought in.
You think the employees devalued the company?
when companies reward their employees by rewriting their options at a lower level as an incentive so they don't have to worry about the fact that they devalued the company by 80% of their original option price.
to buy all afternoon, then moved up 5%
I'm assuming the recent spike was INDV related.
We need more regular news here, surely there is something to report, even if its to tell us progress is being made on the molecules ?
I'm waiting patiently but have to admit its been very disappointing here, I know many peoples averages are much higher than current SP, over 50p.
Wasn't too along ago we were around the 60-100p mark.
Thought that little spike was the start of a re-rate.
Maybe due to the amount if it was a sell.EMS says 3,000 on hargreaves.Even though it isn't a huge amount.
for SP read MCAP!
maybe, but what is the point of communicating something if it is not meaningful.
The point here is the INDV deal looked in serious doubt (I think around 20-25M was gradually wiped off the SP) and now it looks back on track. The initial 15p fund raise was another kick in the nuts but hopefully the worst is now over.
The share is so illiquid that if you get caught out on the wrong side of the trade it can be very painful short term.